Stockreport

Constellation Pharmaceuticals Presents Results from Phase 1b Portion of ProSTAR Clinical Trial of CPI-1205 at AACR Meeting

Constellation Pharmaceuticals, Inc  (CNST) 
Last constellation pharmaceuticals, inc earnings: 3/10 04:12 pm Check Earnings Report
PDF Clinical activity of CPI-1205 was seen in subsets of advanced metastatic castration-resistant prostate cancer (mCRPC) patientsRecently initiated Phase 2 portion of ProST [Read more]